Upregulation of CD147 promotes cell invasion, epithelial-to-mesenchymal transition and activates MAPK/ERK signaling pathway in colorectal cancer

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 11, 2014, Pages 7432-7441

  Xu, Tao ^a   Zhou, Mingliang ^a   Peng, Lipan ^a   Kong, Shuai ^a   Miao, Ruizheng ^a   Shi, Yulong ^a   Sheng, Hongguang ^a   Li, Leping ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

5 FU resistance; CD147; Colorectal cancer; EMT; Invasion; MAPK ERK pathway

Indexed keywords

BSG PROTEIN, HUMAN; CD147 ANTIGEN; FLUOROURACIL; GELATINASE B;

COLORECTAL TUMOR; DRUG RESISTANCE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; MALE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION; UPREGULATION;

ANTIGENS, CD147; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; UP-REGULATION;

EID: 84919475969     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Siegel R, Desantis C and Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin 2014; 64: 104-117.
2. Jeong WJ, Cha PH and Choi KY. Strategies to overcome resistance to epidermal growth factor receptor monoclonal antibody therapy in metastatic colorectal cancer. World J Gastroenterol 2014; 20: 9862-9871.
3. Weidle UH, Scheuer W, Eggle D, Klostermann S and Stockinger H. Cancer-related issues of CD147. Cancer Genomics Proteomics 2010; 7: 157-169.
4. Bai Y, Huang W, Ma LT, Jiang JL and Chen ZN. Importance of N-glycosylation on CD147 for its biological functions. Int J Mol Sci 2014; 15: 6356-6377.
5. Fadool JM and Linser PJ. 5A11 antigen is a cell recognition molecule which is involved in neuronal-glial interactions in avian neural retina. Dev Dyn 1993; 196: 252-262.
6. Yan L, Zucker S and Toole BP. Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression. Thromb Haemost 2005; 93: 199-204.
7. Trachtenberg A, Pushkarsky T, Heine S, Constant S, Brichacek B and Bukrinsky M. The level of CD147 expression correlates with cyclophilin-induced signalling and chemotaxis. BMC Res Notes 2011; 4: 396.
8. Sweeny L, Liu Z, Bush BD, Hartman Y, Zhou T and Rosenthal EL. CD147 and AGR2 expression promote cellular proliferation and metastasis of head and neck squamous cell carcinoma. Exp Cell Res 2012; 318: 1788-1798.
9. Li R, Pan Y, He B, Xu Y, Gao T, Song G, Sun H, Deng Q and Wang S. Downregulation of CD147 expression by RNA interference inhibits HT29 cell proliferation, invasion and tumorigenicity in vitro and in vivo. Int J Oncol 2013; 43: 1885-1894.
10. Zhu S, Chu D, Zhang Y, Wang X, Gong L, Han X, Yao L, Lan M, Li Y and Zhang W. EMMPRIN/CD147 expression is associated with disease-free survival of patients with colorectal cancer. Med Oncol 2013; 30: 369.
11. Sato M, Nakai Y, Nakata W, Yoshida T, Hatano K, Kawashima A, Fujita K, Uemura M, Takayama H and Nonomura N. EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome. PLoS One 2013; 8: e74313.
12. Toole BP and Slomiany MG. Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance. Drug Resist Updat 2008; 11: 110-121.
13. Iacono KT, Brown AL, Greene MI and Saouaf SJ. CD147 immunoglobulin superfamily receptor function and role in pathology. Exp Mol Pathol 2007; 83: 283-295.
14. Jodele S, Blavier L, Yoon JM and DeClerck YA. Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metastasis Rev 2006; 25: 35-43.
15. Zheng HC, Wang W, Xu XY, Xia P, Yu M, Sugiyama T and Takano Y. Up-regulated EMMPRIN/CD147 protein expression might play a role in colorectal carcinogenesis and its subsequent progression without an alteration of its glycosylation and mRNA level. J Cancer Res Clin Oncol 2011; 137: 585-596.
16. Yang JM, Xu Z, Wu H, Zhu H, Wu X and Hait WN. Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Mol Cancer Res 2003; 1: 420-427.
17. Zhao Y, Chen S, Gou WF, Niu ZF, Zhao S, Xiao LJ, Takano Y and Zheng HC. The role of EMMPRIN expression in ovarian epithelial carcinomas. Cell Cycle 2013; 12: 2899-2913.
18. Siu A, Chang J, Lee C, Lee S, Lee C and Ramos DM. Expression of EMMPRIN modulates mediators of tumor invasion in oral squamous cell carcinoma. J Calif Dent Assoc 2013; 41: 831-838.
19. Chen L, Pan Y, Gu L, Nie Z, He B, Song G, Li R, Xu Y, Gao T and Wang S. ERK1/2 signalling pathway is involved in CD147-mediated gastric cancer cell line SGC7901 proliferation and invasion. Exp Biol Med (Maywood) 2013; 238: 903-912.
20. Grass GD, Dai L, Qin Z, Parsons C and Toole BP. CD147: Regulator of Hyaluronan Signaling in Invasiveness and Chemoresistance. Adv Cancer Res 2014; 123: 351-373.
21. Tang Q, Wang Y, Huang R, You Q, Wang G, Chen Y, Jiang Z, Liu Z, Yu L, Muhammad S and Wang X. Preparation of anti-tumor nanoparticle and its inhibition to peritoneal dissemination of colon cancer. PLoS One 2014; 9: e98455.
22. Misra S, Ghatak S, Zoltan-Jones A and Toole BP. Regulation of multidrug resistance in cancer cells by hyaluronan. J Biol Chem 2003; 278: 25285-25288.
23. Kalluri R and Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-1428.
24. Wu J, Hao ZW, Zhao YX, Yang XM, Tang H, Zhang X, Song F, Sun XX, Wang B, Nan G, Chen ZN and Bian H. Full-length soluble CD147 promotes MMP-2 expression and is a potential serological marker in detection of hepatocellular carcinoma. J Transl Med 2014; 12: 190.
25. Gong Y, Chippada-Venkata UD and Oh WK. Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression. Cancers (Basel) 2014; 6: 1298-1327.
26. Roy R, Yang J and Moses MA. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol 2009; 27: 5287-5297.
27. Kessenbrock K, Plaks V and Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010; 141: 52-67.
28. Chen PS, Shih YW, Huang HC and Cheng HW. Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression. PLoS One 2011; 6: e20164.
29. Kim JY, Kim WJ, Kim H, Suk K and Lee WH. The Stimulation of CD147 Induces MMP-9 Expression through ERK and NF-kappaB in Macrophages: Implication for Atherosclerosis. Immune Netw 2009; 9: 90-97.